ULBI

Ultralife Corporation

There isn't enough reported data to score ULBI yet.

VRT

Vertiv Holdings Co

87
Fundamentals85/ 100
Valuation87/ 100
Upside potential86/ 100
Risk potential19/ 100

VRT's fundamentals are strong and it looks cheap: trading at 39x earnings, about half its usual 72x. Analysts expect strong earnings growth.

ULBI Fundamentals

MetricStatus
Stable
Stable
Under pressure
Weak

ULBI's revenue and profitability are currently stable, but its cash flow and balance sheet are under pressure.

VRT Fundamentals

MetricStatus
Strong
Strong
Strong
Strong

VRT's revenue, profitability, cash flow and balance sheet are all currently strong.

ULBI PE Valuation

ULBI has no meaningful PE right now: it lost money over the past year.

VRT PE Valuation

CHEAPFAIREXPENSIVE39x77x116x155x
CHEAPFAIREXPENSIVE39x77x116x155x
LevelPEPriceVs current
Forward23x$210—
Current39x$210—
Cheap58x$308+47%
Fair72x$383+83%
Expensive88x$472+125%

Historical ranges are pointers, not guarantees.

VRT's PE is in its cheap range at 39x. If earnings grow as analysts expect, today's price would be 23x next year's earnings.

ULBI Forward outlook

There aren't enough analyst estimates for ULBI to show an outlook.

VRT Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Moderate
Moderate

Analysts expect strong earnings and revenue growth for VRT, with profitability improving.

ULBI Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $15.78 on Nov 12.

There is not enough scenario data to compare ULBI and VRT's risk to reward.

VRT Risk to reward

ScenarioChangePrice
Upside+122%$466.33
Downside-19%$169.11

Calculated from the latest close: $209.64 on Nov 12.

There is not enough scenario data to compare ULBI and VRT's risk to reward.

ULBI Earnings Per Share

Q4 2024: $0.45Q1 2025: $0.26Q2 2025: $0.10Q3 2025: $0.01
Q4 2024: $0.45Q1 2025: $0.26Q2 2025: $0.10Q3 2025: $0.01

ULBI earned $0.01 per share over the past year, down 97% from the year before.

VRT Earnings Per Share

Q4 2023: $1.19Q1 2024: $1.05Q2 2024: $1.29Q3 2024: $1.51Q4 2024: $1.28Q1 2025: $1.72Q2 2025: $2.09Q3 2025: $2.65Q4 2025: $3.41Q1 2026: $3.98Q2 2026: $4.42Q3 2026: $5.35Forward: $9.14
Q4 2023: $1.19Q1 2024: $1.05Q2 2024: $1.29Q3 2024: $1.51Q4 2024: $1.28Q1 2025: $1.72Q2 2025: $2.09Q3 2025: $2.65Q4 2025: $3.41Q1 2026: $3.98Q2 2026: $4.42Q3 2026: $5.35Forward: $9.14
QuarterTTM EPSYoY
Forward$9.14+71%
Q3 2026$5.35+102%
Q2 2026$4.42+111%
Q1 2026$3.98+131%
Q4 2025$3.41+166%
Q3 2025$2.65+75%
Q2 2025$2.09+62%
Q1 2025$1.72+64%
Q4 2024$1.28+7.6%

VRT has the edge over ULBI in the latest year-over-year earnings comparison.

ULBI Quarterly Revenue

Q4 2023: $45MQ1 2024: $42MQ2 2024: $43MQ3 2024: $36MQ4 2024: $44MQ1 2025: $51MQ2 2025: $49MQ3 2025: $43MQ4 2025: $48MQ1 2026: $47MQ2 2026: $48MQ3 2026: $48M
Q4 2023: $45MQ1 2024: $42MQ2 2024: $43MQ3 2024: $36MQ4 2024: $44MQ1 2025: $51MQ2 2025: $49MQ3 2025: $43MQ4 2025: $48MQ1 2026: $47MQ2 2026: $48MQ3 2026: $48M
QuarterRevenueYoY
Q3 2026$48.3M+11%
Q2 2026$47.9M-1.3%
Q1 2026$47.4M-6.5%
Q4 2025$48.5M+11%
Q3 2025$43.4M+22%
Q2 2025$48.6M+13%
Q1 2025$50.7M+21%
Q4 2024$43.9M-1.6%

ULBI's revenue has held roughly level: $48M last quarter, up 11% from the same quarter a year ago.

VRT Quarterly Revenue

Q4 2023: $1.9BQ1 2024: $1.6BQ2 2024: $2BQ3 2024: $2.1BQ4 2024: $2.3BQ1 2025: $2BQ2 2025: $2.6BQ3 2025: $2.7BQ4 2025: $2.9BQ1 2026: $2.6BQ2 2026: $3.3BQ3 2026: $4.3B
Q4 2023: $1.9BQ1 2024: $1.6BQ2 2024: $2BQ3 2024: $2.1BQ4 2024: $2.3BQ1 2025: $2BQ2 2025: $2.6BQ3 2025: $2.7BQ4 2025: $2.9BQ1 2026: $2.6BQ2 2026: $3.3BQ3 2026: $4.3B
QuarterRevenueYoY
Q3 2026$4.3B+61%
Q2 2026$3.3B+24%
Q1 2026$2.6B+30%
Q4 2025$2.9B+23%
Q3 2025$2.7B+29%
Q2 2025$2.6B+35%
Q1 2025$2B+24%
Q4 2024$2.3B+26%

VRT has the edge over ULBI on sales, with more consistent year-over-year improvement.

ULBI Free Cash Flow

Q4 2023: $1MQ1 2024: −$453,000Q2 2024: $9MQ3 2024: $4MQ4 2024: $2MQ1 2025: $2MQ2 2025: $5MQ3 2025: −$797,000Q4 2025: $607,000Q1 2026: $1MQ2 2026: $735,000Q3 2026: −$4M
Q4 2023: $1MQ1 2024: −$453,000Q2 2024: $9MQ3 2024: $4MQ4 2024: $2MQ1 2025: $2MQ2 2025: $5MQ3 2025: −$797,000Q4 2025: $607,000Q1 2026: $1MQ2 2026: $735,000Q3 2026: −$4M
QuarterFree cash flowYoY
Q3 2026-$3.5M-$2.7M
Q2 2026$735K-85%
Q1 2026$1.5M-40%
Q4 2025$607K-75%
Q3 2025-$797K-119%
Q2 2025$4.8M-44%
Q1 2025$2.5M+$2.9M
Q4 2024$2.4M+71%

ULBI's free cash flow was −$694,000 over the past year, against $9M the year before.

VRT Free Cash Flow

Q4 2023: $308MQ1 2024: $102MQ2 2024: $344MQ3 2024: $342MQ4 2024: $365MQ1 2025: $267MQ2 2025: $278MQ3 2025: $464MQ4 2025: $886MQ1 2026: $654MQ2 2026: $927MQ3 2026: $655M
Q4 2023: $308MQ1 2024: $102MQ2 2024: $344MQ3 2024: $342MQ4 2024: $365MQ1 2025: $267MQ2 2025: $278MQ3 2025: $464MQ4 2025: $886MQ1 2026: $654MQ2 2026: $927MQ3 2026: $655M
QuarterFree cash flowYoY
Q3 2026$654.9M+41%
Q2 2026$926.5M+233%
Q1 2026$654.2M+145%
Q4 2025$885.6M+143%
Q3 2025$463.5M+36%
Q2 2025$277.9M-19%
Q1 2025$266.8M+162%
Q4 2024$364.5M+18%

VRT has the edge over ULBI on cash generation, producing positive trailing cash flow while its opponent burns cash.

ULBI Total Shares

Q4 2023: 16MQ1 2024: 17MQ2 2024: 17MQ3 2024: 17MQ4 2024: 17MQ1 2025: 17MQ2 2025: 17MQ3 2025: 17MQ4 2025: 17MQ1 2026: 17MQ2 2026: 17MQ3 2026: 17M
Q4 2023: 16MQ1 2024: 17MQ2 2024: 17MQ3 2024: 17MQ4 2024: 17MQ1 2025: 17MQ2 2025: 17MQ3 2025: 17MQ4 2025: 17MQ1 2026: 17MQ2 2026: 17MQ3 2026: 17M
PeriodChange %Net change
Quarterly-0.1%-17K shares
1 year+0.3%+51K shares
3 years+2.4%+394K shares
5 years+2.7%+437K shares
Available history+3.2%+518K shares

ULBI has the edge over VRT on shareholder dilution, with a more favorable share count trend.

VRT Total Shares

Q4 2023: 386MQ1 2024: 379MQ2 2024: 384MQ3 2024: 384MQ4 2024: 386MQ1 2025: 390MQ2 2025: 390MQ3 2025: 391MQ4 2025: 391MQ1 2026: 392MQ2 2026: 393MQ3 2026: 393M
Q4 2023: 386MQ1 2024: 379MQ2 2024: 384MQ3 2024: 384MQ4 2024: 386MQ1 2025: 390MQ2 2025: 390MQ3 2025: 391MQ4 2025: 391MQ1 2026: 392MQ2 2026: 393MQ3 2026: 393M
PeriodChange %Net change
Quarterly0%-64.9K shares
1 year+0.4%+1.8M shares
3 years+1.1%+4.4M shares
5 years+10%+36M shares
Available history+63%+152M shares

VRT has 393M diluted shares, about the same as a year ago.

ULBI Net Leverage

Q4 2023: 1.2xQ1 2024: 0.9xQ2 2024: 0.3xQ3 2024: 0.1xQ4 2024: 3.4xQ1 2025: 3.2xQ2 2025: 3.2xQ3 2025: 3.6xQ3 2026: 38.3x
Q4 2023: 1.2xQ1 2024: 0.9xQ2 2024: 0.3xQ3 2024: 0.1xQ4 2024: 3.4xQ1 2025: 3.2xQ2 2025: 3.2xQ3 2025: 3.6xQ3 2026: 38.3x
QuarterNet LeverageStatus
Q3 202638.3xHigh
Q3 20253.6xElevated
Q2 20253.2xElevated
Q1 20253.2xElevated
Q4 20243.4xElevated
Q3 20240.1xVery low
Q2 20240.3xVery low
Q1 20240.9xVery low

ULBI's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.4 years a year ago.

VRT Net Leverage

Q4 2023: 1.9xQ1 2024: 2.2xQ2 2024: 1.8xQ3 2024: 1.4xQ4 2024: 1.0xQ1 2025: 0.8xQ2 2025: 0.7xQ3 2025: 0.8xQ4 2025: 0.6xQ1 2026: 0.3xQ2 2026: 0.1xQ3 2026: -0.2x
Q4 2023: 1.9xQ1 2024: 2.2xQ2 2024: 1.8xQ3 2024: 1.4xQ4 2024: 1.0xQ1 2025: 0.8xQ2 2025: 0.7xQ3 2025: 0.8xQ4 2025: 0.6xQ1 2026: 0.3xQ2 2026: 0.1xQ3 2026: -0.2x
QuarterNet LeverageStatus
Q3 2026-0.2xNet Cash
Q2 20260.1xVery low
Q1 20260.3xVery low
Q4 20250.6xVery low
Q3 20250.8xVery low
Q2 20250.7xVery low
Q1 20250.8xVery low
Q4 20241.0xHealthy

VRT has the edge over ULBI on leverage, with a lower net debt burden relative to earnings.

ULBI Weekly Momentum

MetricValueStatus
RSI82.9Overbought
Stochastic99.6Overbought

ULBI's weekly RSI is 83 (overbought) and its Stochastic is 100 (overbought).

VRT Weekly Momentum

MetricValueStatus
RSI43.0Neutral
Stochastic26.4Neutral

VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).

ULBI PE vs Industrials Sector

MetricULBISector medianRelative
PEN/A24x—

ULBI has no meaningful PE right now: it lost money over the past year.

VRT PE vs Industrials Sector

MetricVRTSector medianRelative
PE39x24x63% above
PE %35855 pts below

VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.

ULBI Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$9.7662% above
20 week MA$7.54109% above
50 week MA$6.82131% above
100 week MA$6.76133% above
200 week MA$7.29116% above

ULBI has the edge over VRT on trend strength, trading above more of its moving averages.

VRT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$221.85.5% below
20 week MA$254.418% below
50 week MA$253.917% below
100 week MA$189.111% above
200 week MA$123.570% above

VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.

ULBI Yearly ROI

YearStart priceEnd priceROI
2020$7.29$6.36-13%
2021$6.36$5.96-6.3%
2022$5.96$3.89-35%
2023$3.89$6.82+75%
2024$6.82$7.29+6.9%
2025$7.29$5.76-21%
2026 YTD$5.76$15.8+174%

ULBI has the edge over VRT on returns for 2026, with the stronger performance.

VRT Yearly ROI

YearStart priceEnd priceROI
2020$10.9$18.9+73%
2021$18.9$24.9+31%
2022$24.9$12.8-48%
2023$12.8$48.0+275%
2024$48.0$115.1+140%
2025$115.1$167.6+46%
2026 YTD$167.6$209.6+25%

VRT's yearly returns have swung widely, from +275% in 2023 to −48% in 2022. It's up 25% so far in 2026.

Give your agent the market.

Get API key